Corgenix Announces Initial Phase Completion of Clinical Trial of Rapid Test for Lassa Fever
Tuesday, April 23, 2013
First-to-market, point-of-care rapid diagnostic test based on recombinant antigen technology for the detection of Lassa viral hemorrhagic fever filed for CE Marking.
ARCA biopharma and Medtronic Collaborate
Tuesday, April 23, 2013
Companies partner on atrial fibrillation clinical trial for GencaroTM .
Algeta’s Partner Bayer Submits Radium-223 for EU Marketing Authorization
Monday, April 22, 2013
Submission to trigger €50 million milestone payment to Algeta.
Advanced Clinical Announces New Executive Vice President
Monday, April 22, 2013
Julie A. Ross appointed as Executive Vice President, CRO Operations.
DSM and DecImmune Therapeutics Sign Agreement
Monday, April 22, 2013
Agreement to develop N2 pathway blocking antibody.
Galapagos Discovers Novel Candidate Drug to Treat Breast Cancer
Monday, April 22, 2013
GLPG1790 has high efficacy against triple-negative breast cancer.
Man Jailed in Pre-Clinical Trial Data Scam Case
Friday, April 19, 2013
The man was sentenced to three months in prison for altering pre-clinical trial data designed to support applications to perform clinical trials.
Covance Expands Singapore Central Laboratory
Friday, April 19, 2013
The expansion doubles genomics footprint, adds anatomic pathology and nutritional chemistry capabilities.
BioLineRx Announces Positive Phase II Results for BL-7040
Friday, April 19, 2013
BL-7040 met the primary efficacy endpoint of the study.
|
|
|
|
|
|
